Thorne Research, Inc, WellnessFX, and Itamar Medical, Maker of the EndoPAT

Thorne Research, Inc, WellnessFX, And Itamar Medical, Maker Of The EndoPAT

Filed under: Houston Drug Treatment

The Hypertension Institute, under the direction of Mark Houston MD, MS, MSc, and Thorne Research, have jointly developed the TruCardia® line of nutritional supplements for the support of cardiovascular health. The Hypertension Institute and Thorne …
Read more on PR Newswire (press release)

 

A Pill 'Melts Away' Common Form of Leukemia

Filed under: Houston Drug Treatment

Because it targets B cells, Dr. Furman is using the drug as a first-line treatment for all of his CLL patients — even those who are newly diagnosed. "I am now able to avoid all … The Medical College is also affiliated with Houston Methodist. For …
Read more on eNews Park Forest

 

Mocetinostat In Combination With Vidaza Shows High Activity In MDS Patients

Filed under: Houston Drug Treatment

… independence. Dr. Guillermo Garcia-Manero from the M.D. Anderson Cancer Center in Houston presented the results during a poster session at the American Society of Hematology (ASH) annual meeting last month. … Other HDAC inhibitors that have been …
Read more on The MDS Beacon

 

Text of NJ Gov. Chris Christie's inaugural address

Filed under: Houston Drug Treatment

We will end the failed war on drugs that believes that incarceration is the cure of every ill caused by drug abuse. We will make drug treatment available to as many of our non-violent offenders as we can and we will partner with our citizens to create …
Read more on Houston Chronicle